Department of Neurology, University of California Irvine, Irvine, California, USA.
Department of Neurology, Huashan Hospital Fudan University, Shanghai, China.
Stroke Vasc Neurol. 2019 Nov 7;5(1):65-70. doi: 10.1136/svn-2019-000261. eCollection 2020.
Stroke is a leading cause of adult mortality and disability worldwide. Extracranial atherosclerotic disease (ECAD), primarily, carotid artery stenosis, accounts for approximately 18%-25% of ischaemic stroke. Recent advances in neuroimaging, medical therapy and interventional management have led to A significant reduction of stroke from carotid artery stenosis. The current treatment of ECAD includes optimal medical therapy, carotid endarterectomy (CEA) and carotid artery stenting (CAS). The selection of treatments depends on symptomatic status, severity of stenosis, individual factors, efficacy and risk of complications. The aim of this paper is to review current evidence and guidelines on the management of carotid artery stenosis, including the comparison of medical and interventional therapy (CAS and CEA), as well as future directions.
中风是全球成年人死亡和残疾的主要原因。颅外动脉粥样硬化疾病(ECAD)主要是颈动脉狭窄,约占缺血性中风的 18%-25%。神经影像学、医学治疗和介入管理的最新进展导致颈动脉狭窄引起的中风显著减少。目前对 ECAD 的治疗包括最佳药物治疗、颈动脉内膜切除术(CEA)和颈动脉支架置入术(CAS)。治疗方法的选择取决于症状状态、狭窄程度、个体因素、疗效和并发症风险。本文旨在回顾颈动脉狭窄管理的现有证据和指南,包括药物和介入治疗(CAS 和 CEA)的比较,以及未来的方向。